{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:31:46Z","timestamp":1768354306974,"version":"3.49.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Breast cancer (BC) is a complex disease with high heterogeneity, which often leads to great differences in treatment results. Current common molecular typing method is PAM50, which shows positive results for precision medicine; however, room for improvement still remains because of the different prognoses of subtypes. Therefore, in this article, we used lncRNAs, which are more tissue-specific and developmental stage-specific than other RNAs, as typing markers and combined single-cell expression profiles to retype BC, to provide a new method for BC classification and explore new precise therapeutic strategies based on this method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Based on lncRNA expression profiles of 317 single cells from 11\u2009BC patients, SC3 was used to retype BC, and differential expression analysis and enrichment analysis were performed to identify biological characteristics of new subtypes. The results were validated for survival analysis using data from TCGA. Then, the downstream regulatory genes of lncRNA markers of each subtype were searched by expression correlation analysis, and these genes were used as targets to screen therapeutic drugs, thus proposing new precision treatment strategies according to the different subtype compositions of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seven lncRNA subtypes and their specific biological characteristics are obtained. Then, 57 targets and 210 drugs of 7 subtypes were acquired. New precision medicine strategies were proposed according to the different compositions of patient subtypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>For patients with different subtype compositions, we propose a strategy to select different drugs for different patients, which means using drugs targeting multi subtype or combinations of drugs targeting a single subtype to simultaneously kill different cancer cells by personalized treatment, thus reducing the possibility of drug resistance and even recurrence.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-021-08617-7","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T05:03:14Z","timestamp":1628830994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level"],"prefix":"10.1186","volume":"21","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingkang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"issue":"2","key":"8617_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262.","journal-title":"CA Cancer J Clin"},{"key":"8617_CR2","doi-asserted-by":"publisher","first-page":"117009","DOI":"10.1016\/j.lfs.2019.117009","volume":"239","author":"I Janu\u0161kevi\u010dien\u0117","year":"2019","unstructured":"Janu\u0161kevi\u010dien\u0117 I, Petrikait\u0117 V. Heterogeneity of breast cancer: the importance of interaction between different tumor cell populations. Life Sci. 2019;239:117009. https:\/\/doi.org\/10.1016\/j.lfs.2019.117009.","journal-title":"Life Sci"},{"key":"8617_CR3","doi-asserted-by":"publisher","unstructured":"Cui Q, Tang J, Zhang D, Kong D, Liao X, Ren J, et al. A prognostic eight-gene expression signature for patients with breast cancer receiving adjuvant chemotherapy. J Cell Biochem. 2020;121:3923\u201334. https:\/\/doi.org\/10.1002\/jcb.29550.","DOI":"10.1002\/jcb.29550"},{"key":"8617_CR4","doi-asserted-by":"crossref","unstructured":"Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More? J Natl Cancer Inst. 2014;106(8):dju165.","DOI":"10.1093\/jnci\/dju165"},{"issue":"6871","key":"8617_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van\u2019t Veer","year":"2002","unstructured":"van\u2019t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530\u20136.","journal-title":"Nature"},{"issue":"8","key":"8617_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso F, van\u2019t Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, et al. 70-gene signature as an aid to treatment decisions in early-stage breast Cancer. N Engl J Med. 2016;375(8):717\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1602253.","journal-title":"N Engl J Med"},{"issue":"21","key":"8617_CR7","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","volume":"373","author":"JA Sparano","year":"2015","unstructured":"Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Prospective validation of a 21-gene expression assay in breast Cancer. N Engl J Med. 2015;373(21):2005\u201314. https:\/\/doi.org\/10.1056\/NEJMoa1510764.","journal-title":"N Engl J Med"},{"issue":"8","key":"8617_CR8","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast Cancer based on intrinsic subtypes. J Clin Oncol. 2009;27(8):1160\u20137. https:\/\/doi.org\/10.1200\/JCO.2008.18.1370.","journal-title":"J Clin Oncol"},{"issue":"7418","key":"8617_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","journal-title":"Nature"},{"issue":"6797","key":"8617_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352. https:\/\/doi.org\/10.1038\/35021093.","journal-title":"Nature"},{"issue":"1","key":"8617_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10549-012-2143-0","volume":"135","author":"A Prat","year":"2012","unstructured":"Prat A, Parker JS, Fan C, Perou CM. PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012;135(1):301\u20136. https:\/\/doi.org\/10.1007\/s10549-012-2143-0.","journal-title":"Breast Cancer Res Treat"},{"key":"8617_CR12","doi-asserted-by":"crossref","unstructured":"Gadi VK, Davidson NE. Practical Approach to Triple-Negative Breast Cancer. J Oncol Pract. 2017;\u00a0 13(5):293\u2013300.","DOI":"10.1200\/JOP.2017.022632"},{"key":"8617_CR13","doi-asserted-by":"crossref","unstructured":"Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, et al. Presenting Features of Breast Cancer Differ by Molecular Subtype. Ann Surg Oncol. 2009;16(10):2705\u201310.","DOI":"10.1245\/s10434-009-0606-2"},{"issue":"2","key":"8617_CR14","first-page":"55","volume":"40","author":"B W\u00f6rmann","year":"2017","unstructured":"W\u00f6rmann B. Breast cancer: basics, screening, diagnostics and treatment. Med Monatsschr Pharm. 2017;40(2):55\u201364.","journal-title":"Med Monatsschr Pharm"},{"issue":"29","key":"8617_CR15","doi-asserted-by":"publisher","first-page":"26560","DOI":"10.18632\/oncotarget.5306","volume":"6","author":"G Palma","year":"2015","unstructured":"Palma G, Frasci G, Chirico A, Esposito E, Siani C, Saturnino C, et al. Triple negative breast cancer: looking for the missing link between biology and treatments. Oncotarget. 2015;6(29):26560\u201374. https:\/\/doi.org\/10.18632\/oncotarget.5306.","journal-title":"Oncotarget"},{"issue":"2","key":"8617_CR16","doi-asserted-by":"publisher","first-page":"R24","DOI":"10.1186\/bcr1666","volume":"9","author":"A Vincent-Salomon","year":"2007","unstructured":"Vincent-Salomon A, Gruel N, Lucchesi C, Macgrogan G, Aurias A. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res. 2007;9(2):R24. https:\/\/doi.org\/10.1186\/bcr1666.","journal-title":"Breast Cancer Res"},{"key":"8617_CR17","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves A, Sabatier R, Charafejauffret E. Triple-negative breast cancer histoclinical and molecular features, therapeutic management and perspectives. Bull Cancer. 2013;100(5):453\u201364.","DOI":"10.1684\/bdc.2013.1740"},{"issue":"8","key":"8617_CR18","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn HJ. Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast Cancer 2011. Ann Oncol. 2011;22(8):1736\u201347. https:\/\/doi.org\/10.1093\/annonc\/mdr304.","journal-title":"Ann Oncol"},{"issue":"2","key":"8617_CR19","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4143\/crt.2018.342","volume":"51","author":"HK Kim","year":"2019","unstructured":"Kim HK, Park KH, Kim Y, Park SE, Lee HS, Lim SW, et al. Discordance of the PAM50 intrinsic subtypes compared with immunohistochemistry-based surrogate in breast Cancer patients: potential implication of genomic alterations of discordance. Cancer Res Treat. 2019;51(2):737\u201347. https:\/\/doi.org\/10.4143\/crt.2018.342.","journal-title":"Cancer Res Treat"},{"issue":"32","key":"8617_CR20","doi-asserted-by":"publisher","first-page":"53763","DOI":"10.18632\/oncotarget.17893","volume":"8","author":"S Zhu","year":"2017","unstructured":"Zhu S, Qing T, Zheng Y, Jin L, Shi L. Advances in single-cell RNA sequencing and its applications in cancer research. Oncotarget. 2017;8(32):53763\u201379. https:\/\/doi.org\/10.18632\/oncotarget.17893.","journal-title":"Oncotarget"},{"key":"8617_CR21","first-page":"99","volume-title":"Chemical Diagnostics: From Bench to Bedside","author":"M Shirai","year":"2014","unstructured":"Shirai M, Taniguchi T, Kambara H. Emerging Applications of Single-Cell Diagnostics. In: Tang NLS, Poon T, editors. Chemical Diagnostics: From Bench to Bedside. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. p. 99\u2013116."},{"issue":"6","key":"8617_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.molmed.2017.04.006","volume":"23","author":"D Ofengeim","year":"2017","unstructured":"Ofengeim D, Giagtzoglou N, Huh D, Zou C, Yuan J. Single-cell RNA sequencing: unraveling the Brain one cell at a time. Trends Mol Med. 2017;23(6):563\u201376. https:\/\/doi.org\/10.1016\/j.molmed.2017.04.006.","journal-title":"Trends Mol Med"},{"issue":"8","key":"8617_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41581-018-0021-7","volume":"14","author":"SS Potter","year":"2018","unstructured":"Potter SS. Single-cell RNA sequencing for the study of development, physiology and disease. Nat Rev Nephrol. 2018;14(8):479\u201392. https:\/\/doi.org\/10.1038\/s41581-018-0021-7.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"8617_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrc.2017.58","volume":"17","author":"T Baslan","year":"2017","unstructured":"Baslan T, Hicks J. Unravelling biology and shifting paradigms in cancer with single-cell sequencing. Nat Rev Cancer. 2017;17(9):557\u201369. https:\/\/doi.org\/10.1038\/nrc.2017.58.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"8617_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1200\/JCO.2007.14.3222","volume":"26","author":"F Cardoso","year":"2008","unstructured":"Cardoso F, Veer LVT, Rutgers E, Loi S, Piccart-Gebhart MJ. Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol. 2008;26(5):729\u201335. https:\/\/doi.org\/10.1200\/JCO.2007.14.3222.","journal-title":"J Clin Oncol"},{"issue":"1","key":"8617_CR26","doi-asserted-by":"publisher","first-page":"15081","DOI":"10.1038\/ncomms15081","volume":"8","author":"W Chung","year":"2017","unstructured":"Chung W, Eum HH, Lee H-O, Lee K-M, Lee H-B, Kim K-T, et al. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun. 2017;8(1):15081. https:\/\/doi.org\/10.1038\/ncomms15081.","journal-title":"Nat Commun"},{"issue":"18","key":"8617_CR27","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1101\/gad.17446611","volume":"25","author":"MN Cabili","year":"2011","unstructured":"Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25(18):1915\u201327. https:\/\/doi.org\/10.1101\/gad.17446611.","journal-title":"Genes Dev"},{"key":"8617_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fgene.2012.00219","volume":"3","author":"K Tano","year":"2012","unstructured":"Tano K, Akimitsu N. Long non-coding RNAs in cancer progression. Front Genet. 2012;3:219.","journal-title":"Front Genet"},{"issue":"3","key":"8617_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.4161\/rna.8.3.14800","volume":"8","author":"JM Silva","year":"2011","unstructured":"Silva JM, Boczek NJ, Berres MW, Ma X, Smith DI. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011;8(3):496\u2013505. https:\/\/doi.org\/10.4161\/rna.8.3.14800.","journal-title":"RNA Biol"},{"issue":"483","key":"8617_CR30","doi-asserted-by":"publisher","first-page":"aak9557","DOI":"10.1126\/scisignal.aak9557","volume":"10","author":"W Zhou","year":"2017","unstructured":"Zhou W, Ye XL, Xu J, Cao MG, Fang ZY, Li LY, et al. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b\/c and let-7b. Sci Signal. 2017;10(483):aak9557.","journal-title":"Sci Signal"},{"issue":"13","key":"8617_CR31","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1093\/nar\/gkp441","volume":"37","author":"C Cooper","year":"2009","unstructured":"Cooper C, Guo J, Yan Y, Chooniedass-Kothari S, Hube F, Hamedani MK, et al. Increasing the relative expression of endogenous non-coding steroid receptor RNA activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res. 2009;37(13):4518\u201331. https:\/\/doi.org\/10.1093\/nar\/gkp441.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"8617_CR32","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1261\/rna.2528811","volume":"17","author":"ME Askarian-Amiri","year":"2011","unstructured":"Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, Clark MB, et al. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA (New York, NY). 2011;17(5):878\u201391.","journal-title":"RNA (New York, NY)"},{"issue":"Database issue","key":"8617_CR33","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41(Database issue):D991\u20135. https:\/\/doi.org\/10.1093\/nar\/gks1193.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"8617_CR34","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1101\/gr.135350.111","volume":"22","author":"J Harrow","year":"2012","unstructured":"Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, et al. GENCODE: the reference human genome annotation for the ENCODE project. Genome Res. 2012;22(9):1760\u201374. https:\/\/doi.org\/10.1101\/gr.135350.111.","journal-title":"Genome Res"},{"key":"8617_CR35","volume-title":"Rtsne: T-distributed stochastic neighbor embedding using Barnes-Hut implementation. R package version 013","author":"JH Krijthe","year":"2015","unstructured":"Krijthe JH: Rtsne: T-distributed stochastic neighbor embedding using Barnes-Hut implementation. R package version 013, 2015. https:\/\/github.com\/jkrijthe\/Rtsne."},{"key":"8617_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.csda.2016.05.003","volume":"103","author":"ML Hazelton","year":"2016","unstructured":"Hazelton ML, Cox MP. Bandwidth selection for kernel log-density estimation. Comput Stat Data Anal. 2016;103:56\u201367. https:\/\/doi.org\/10.1016\/j.csda.2016.05.003.","journal-title":"Comput Stat Data Anal"},{"issue":"1","key":"8617_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14(1):7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"8617_CR38","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","volume":"32","author":"DM Gendoo","year":"2016","unstructured":"Gendoo DM, Ratanasirigulchai N, Schr\u00f6der MS, Par\u00e9 L, Parker JS, Prat A, et al. Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer. Bioinformatics (Oxford, England). 2016;32(7):1097\u20139.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"16","key":"8617_CR39","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/bioinformatics\/bty1044","volume":"35","author":"TS Andrews","year":"2018","unstructured":"Andrews TS, Hemberg M. M3Drop: dropout-based feature selection for scRNASeq. Bioinformatics. 2018;35(16):2865\u20137.","journal-title":"Bioinformatics"},{"issue":"1","key":"8617_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics. 2010;11(1):367. https:\/\/doi.org\/10.1186\/1471-2105-11-367.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"8617_CR41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nmeth.4236","volume":"14","author":"VY Kiselev","year":"2017","unstructured":"Kiselev VY, Kirschner K, Schaub MT, Andrews T, Hemberg M. SC3: consensus clustering of single-cell RNA-seq data. Nat Methods. 2017;14(5):483\u20136. https:\/\/doi.org\/10.1038\/nmeth.4236.","journal-title":"Nat Methods"},{"issue":"2","key":"8617_CR42","doi-asserted-by":"publisher","first-page":"1700232","DOI":"10.1002\/pmic.201700232","volume":"18","author":"B Wang","year":"2018","unstructured":"Wang B, Ramazzotti D, De Sano L, Zhu J, Pierson E, Batzoglou S. SIMLR: a tool for large-scale genomic analyses by multi-kernel learning. PROTEOMICS. 2018;18(2):1700232. https:\/\/doi.org\/10.1002\/pmic.201700232.","journal-title":"PROTEOMICS"},{"issue":"2","key":"8617_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.stem.2016.05.010","volume":"19","author":"D Gr\u00fcn","year":"2016","unstructured":"Gr\u00fcn D, Muraro MJ, Boisset J-C, Wiebrands K, Lyubimova A, Dharmadhikari G, et al. De novo prediction of stem cell identity using single-cell transcriptome data. Cell Stem Cell. 2016;19(2):266\u201377. https:\/\/doi.org\/10.1016\/j.stem.2016.05.010.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"8617_CR44","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;177(7):1888\u20131902.e1821.","journal-title":"Cell"},{"issue":"1","key":"8617_CR45","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1038\/s41467-020-16904-3","volume":"11","author":"B Liu","year":"2020","unstructured":"Liu B, Li C, Li Z, Wang D, Ren X, Zhang Z. An entropy-based metric for assessing the purity of single cell populations. Nat Commun. 2020;11(1):3155. https:\/\/doi.org\/10.1038\/s41467-020-16904-3.","journal-title":"Nat Commun"},{"key":"8617_CR46","first-page":"2122","volume":"5","author":"AT Lun","year":"2016","unstructured":"Lun AT, McCarthy DJ, Marioni JC. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Research. 2016;5:2122.","journal-title":"F1000Research"},{"issue":"5","key":"8617_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"Omics"},{"issue":"1","key":"8617_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12937-020-00581-5","volume":"19","author":"M Harmouche-Karaki","year":"2020","unstructured":"Harmouche-Karaki M, Mahfouz M, Obeyd J, Salameh P, Mahfouz Y, Helou K. Development and validation of a quantitative food frequency questionnaire to assess dietary intake among Lebanese adults. Nutr J. 2020;19(1):65. https:\/\/doi.org\/10.1186\/s12937-020-00581-5.","journal-title":"Nutr J"},{"issue":"suppl_1","key":"8617_CR49","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34(suppl_1):D668\u201372.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"8617_CR50","doi-asserted-by":"publisher","first-page":"D1031","DOI":"10.1093\/nar\/gkz981","volume":"48","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang S, Li F, Zhou Y, Zhang Y, Wang Z, et al. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res. 2020;48(D1):D1031\u2013d1041. https:\/\/doi.org\/10.1093\/nar\/gkz981.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"8617_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.4306","volume":"23","author":"SM Corsello","year":"2017","unstructured":"Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, et al. The drug repurposing hub: a next-generation drug library and information resource. Nat Med. 2017;23(4):405\u20138. https:\/\/doi.org\/10.1038\/nm.4306.","journal-title":"Nat Med"},{"issue":"10","key":"8617_CR52","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MC Cheang","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101(10):736\u201350. https:\/\/doi.org\/10.1093\/jnci\/djp082.","journal-title":"J Natl Cancer Inst"},{"key":"8617_CR53","doi-asserted-by":"crossref","unstructured":"Laka K, Makgoo L, Mbita Z. Survivin Splice Variants in Arsenic Trioxide (As2O3)-Induced Deactivation of PI3K and MAPK Cell Signalling Pathways in MCF-7 Cells. Genes. 2019;10(1):41.","DOI":"10.3390\/genes10010041"},{"key":"8617_CR54","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3389\/fonc.2019.01325","volume":"9","author":"S Guo","year":"2019","unstructured":"Guo S, Jian L, Tao K, Chen C, Yu H, Liu S. Novel breast-specific long non-coding RNA LINC00993 acts as a tumor suppressor in triple-negative breast Cancer. Front Oncol. 2019;9:1325. https:\/\/doi.org\/10.3389\/fonc.2019.01325.","journal-title":"Front Oncol"},{"issue":"11","key":"8617_CR55","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3390\/ijms18112319","volume":"18","author":"J Collette","year":"2017","unstructured":"Collette J, Le Bourhis X, Adriaenssens E. Regulation of human breast Cancer by the long non-coding RNA H19. Int J Mol Sci. 2017;18(11):2319. https:\/\/doi.org\/10.3390\/ijms18112319.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"8617_CR56","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4103\/jcrt.JCRT_208_19","volume":"15","author":"Z Sun","year":"2019","unstructured":"Sun Z, Zhang C, Wang T, Shi P, Tian X, Guo Y. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer. J Cancer Res Ther. 2019;15(4):933\u201340.","journal-title":"J Cancer Res Ther"},{"key":"8617_CR57","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.2147\/OTT.S172379","volume":"11","author":"H Gao","year":"2018","unstructured":"Gao H, Hao G, Sun Y, Li L, Wang Y. Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process. Onco Targets Ther. 2018;11:8001\u201312. https:\/\/doi.org\/10.2147\/OTT.S172379.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"8617_CR58","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10549-018-4793-z","volume":"170","author":"H Shima","year":"2018","unstructured":"Shima H, Kida K, Adachi S, Yamada A, Sugae S, Narui K, et al. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness. Breast Cancer Res Treat. 2018;170(3):507\u201316. https:\/\/doi.org\/10.1007\/s10549-018-4793-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"8617_CR59","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/mc.22941","volume":"58","author":"WH Liang","year":"2019","unstructured":"Liang WH, Li N, Yuan ZQ, Qian XL, Wang ZH. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2. Mol Carcinog. 2019;58(4):461\u201373. https:\/\/doi.org\/10.1002\/mc.22941.","journal-title":"Mol Carcinog"},{"key":"8617_CR60","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.2147\/CMAR.S198624","volume":"11","author":"S Zheng","year":"2019","unstructured":"Zheng S, Li M, Miao K, Xu H. SNHG1 contributes to proliferation and invasion by regulating miR-382 in breast cancer. Cancer Manag Res. 2019;11:5589\u201398. https:\/\/doi.org\/10.2147\/CMAR.S198624.","journal-title":"Cancer Manag Res"},{"issue":"Pt A","key":"8617_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijbiomac.2018.06.033","volume":"118","author":"X Pei","year":"2018","unstructured":"Pei X, Wang X, Li H. LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448\/IDO. Int J Biol Macromol. 2018;118(Pt A):24\u201330. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.06.033.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"8617_CR62","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12967-018-1611-7","volume":"16","author":"SF Josephs","year":"2018","unstructured":"Josephs SF, Ichim TE, Prince SM, Kesari S, Marincola FM, Escobedo AR, et al. Unleashing endogenous TNF-alpha as a cancer immunotherapeutic. J Transl Med. 2018;16(1):242. https:\/\/doi.org\/10.1186\/s12967-018-1611-7.","journal-title":"J Transl Med"},{"issue":"10","key":"8617_CR63","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889\u201396. https:\/\/doi.org\/10.1038\/ni.1937.","journal-title":"Nat Immunol"},{"issue":"9","key":"8617_CR64","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","volume":"72","author":"EA Carswell","year":"1975","unstructured":"Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975;72(9):3666\u201370. https:\/\/doi.org\/10.1073\/pnas.72.9.3666.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8617_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","volume":"43","author":"D Cruceriu","year":"2020","unstructured":"Cruceriu D, Baldasici O, Balacescu O, Berindan-Neagoe I. The dual role of tumor necrosis factor-alpha (TNF-\u03b1) in breast cancer: molecular insights and therapeutic approaches. Cell Oncol (Dordrecht). 2020;43(1):1\u201318. https:\/\/doi.org\/10.1007\/s13402-019-00489-1.","journal-title":"Cell Oncol (Dordrecht)"},{"issue":"13","key":"8617_CR66","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1158\/0008-5472.CAN-12-3946","volume":"73","author":"M Yu","year":"2013","unstructured":"Yu M, Zhou X, Niu L, Lin G, Huang J, Zhou W, et al. Targeting transmembrane TNF-\u03b1 suppresses breast cancer growth. Cancer Res. 2013;73(13):4061\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3946.","journal-title":"Cancer Res"},{"issue":"2","key":"8617_CR67","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","volume":"175","author":"T Hagemann","year":"2005","unstructured":"Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, et al. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol (Baltimore, Md : 1950). 2005;175(2):1197\u2013205.","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"3","key":"8617_CR68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0006-2952(00)00529-3","volume":"61","author":"S Liekens","year":"2001","unstructured":"Liekens S, De Clercq E, Neyts J. Angiogenesis: regulators and clinical applications. Biochem Pharmacol. 2001;61(3):253\u201370. https:\/\/doi.org\/10.1016\/S0006-2952(00)00529-3.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"8617_CR69","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1053\/jpsu.2001.24735","volume":"36","author":"K Bj\u00f8rnland","year":"2001","unstructured":"Bj\u00f8rnland K, Bratland A, Rugnes E, Pettersen S, Johansen HT, Aasen AO, et al. Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells. J Pediatr Surg. 2001;36(7):1040\u20134. https:\/\/doi.org\/10.1053\/jpsu.2001.24735.","journal-title":"J Pediatr Surg"},{"issue":"21","key":"8617_CR70","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1021\/jm060460o","volume":"49","author":"G Wang","year":"2006","unstructured":"Wang G, Nikolovska-Coleska Z, Yang CY, Wang R, Tang G, Guo J, et al. Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem. 2006;49(21):6139\u201342. https:\/\/doi.org\/10.1021\/jm060460o.","journal-title":"J Med Chem"},{"issue":"1","key":"8617_CR71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40273-017-0556-7","volume":"36","author":"H Squires","year":"2018","unstructured":"Squires H, Pandor A, Thokala P, Stevens JW, Kaltenthaler E, Clowes M, et al. Pertuzumab for the neoadjuvant treatment of early-stage HER2-positive breast Cancer: an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics. 2018;36(1):29\u201338. https:\/\/doi.org\/10.1007\/s40273-017-0556-7.","journal-title":"PharmacoEconomics"},{"issue":"1","key":"8617_CR72","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12282-016-0690-7","volume":"24","author":"E Nooshinfar","year":"2017","unstructured":"Nooshinfar E, Safaroghli-Azar A, Bashash D, Akbari ME. Melatonin, an inhibitory agent in breast cancer. Breast cancer (Tokyo, Japan). 2017;24(1):42\u201351.","journal-title":"Breast cancer (Tokyo, Japan)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08617-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08617-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08617-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T08:59:10Z","timestamp":1673081950000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08617-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8617"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08617-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"assertion":[{"value":"8 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"918"}}